Found: 10
Select item for more details and to access through your institution.
First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Organ Biomarker Responses in Patients With Light Chain Amyloidosis Treated With NEOD001 Are Independent of Previous Hematologic Response.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e97, doi. 10.1016/j.clml.2017.03.175
- By:
- Publication type:
- Article
NEOD001 Demonstrates Organ Biomarker Responses in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From a Phase 1/2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e22, doi. 10.1016/j.clml.2017.03.038
- By:
- Publication type:
- Article
Aβ Immunotherapy: Lessons Learned for Potential Treatment of Alzheimer’s Disease.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 5, p. 255, doi. 10.1159/000090365
- By:
- Publication type:
- Article
Rapid Communication: Characterization of β-Amyloid Peptide from Human Cerebrospinal Fluid.
- Published in:
- Journal of Neurochemistry, 1993, v. 61, n. 5, p. 1965, doi. 10.1111/j.1471-4159.1993.tb09841.x
- By:
- Publication type:
- Article
Analysis and Quantitation of the β-Amyloid Precursor Protein in the Cerebrospinal Fluid of Alzheimer's Disease Patients with a Monoclonal Antibody-Based Immunoassay.
- Published in:
- Journal of Neurochemistry, 1991, v. 56, n. 3, p. 1037, doi. 10.1111/j.1471-4159.1991.tb02026.x
- By:
- Publication type:
- Article
S3-02-05: Immunotherapy
- Published in:
- 2007
- By:
- Publication type:
- Abstract
Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071634
- By:
- Publication type:
- Article
Cerebrospinal fluid levels of amyloid β-protein in alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein e genotype.
- Published in:
- Annals of Neurology, 1995, v. 37, n. 4, p. 512, doi. 10.1002/ana.410370414
- By:
- Publication type:
- Article
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 10, p. 1206, doi. 10.1001/jamaneurol.2018.1487
- By:
- Publication type:
- Article